ALB and hepatocellular carcinoma: Previous studies have indicated the systemic inflammatory markers, such as the neutrophil-to-lymphocyte ratio (NLR) [16,17], platelet-to-lymphocyte ratio (PLR) [17], C-reactive protein-to-albumin ratio (CAR) [18], as predictors of HCC outcome.